On May 16, RunSafe Security, Inc., creator of a patented cyberhardening process for vulnerable embedded systems and devices across critical infrastructure, announced the closing of a $2.4 million seed funding round led by Alsop Louie Partners, an early-stage, risk-oriented technology venture capital firm in San Francisco.

2018-05-18T00:00:00-04:002018-05-18T19:56:11Z

Today, as part of the Trump Administration's stated goal to lower drug prices, the Food and Drug Administration (FDA) published a list of pharmaceutical companies that have allegedly refused to sell samples of their drugs to generic manufacturers.

2018-05-17T00:00:00-04:002018-05-24T15:45:24ZMark A. Fordhttps://www.wilmerhale.com/mark_ford/mark.ford@wilmerhale.comPeter A. Spaethhttps://www.wilmerhale.com/peter_spaeth/peter.spaeth@wilmerhale.comHolly A. Ovingtonhttps://www.wilmerhale.com/holly_ovington/holly.ovington@wilmerhale.com

A blog post by Lloyd Firth, published on the WilmerHale W.I.R.E. UK blog.

2018-05-17T00:00:00-04:002018-05-17T16:50:03ZLloyd Firthhttps://www.wilmerhale.com/lloyd_firth/lloyd.firth@wilmerhale.com

Managing Intellectual Property's 2018 IP Stars Handbook recognizes WilmerHale and 19 of its partners as leaders in the field. IP Stars identifies lawyers based on their knowledge, outcomes achieved for clients and unique strengths in the given practice area.

2018-05-17T00:00:00-04:002018-05-17T22:02:51Z

A blog post by Anna Gaudoin, published on the WilmerHale W.I.R.E. UK blog. 

2018-05-17T00:00:00-04:002018-05-17T13:41:00ZAnna Gaudoinhttps://www.wilmerhale.com/anna_gaudoin/anna.gaudoin@wilmerhale.com

Notwithstanding the venerable status of the attorney-client privilege and the important purposes it serves, the federal banking regulators and the Consumer Financial Protection Bureau have taken the position that they have the legal authority to override the privilege and compel supervised institutions to produce information protected by the privilege.

2018-05-16T00:00:00-04:002018-05-16T14:40:09Z

On May 1, 2018, Sebela Pharmaceuticals completed the acquisition of Braintree Laboratories Inc., a privately held specialty pharmaceutical company based in Braintree, Massachusetts. Braintree develops, manufactures and markets specialty pharmaceuticals in gastroenterology.

2018-05-10T00:00:00-04:002018-05-10T19:55:29Z

On May 14, 2018, the Supreme Court granted WilmerHale client PNC Bank National Association's (PNC Bank) petition for writ of certiorari and vacated a decision of the US Court of Appeals for the Federal Circuit restricting the availability of covered business method (CBM) review.

2018-05-16T00:00:00-04:002018-05-16T21:48:13ZGregory H. Lantierhttps://www.wilmerhale.com/gregory_lantier/gregory.lantier@wilmerhale.comBrittany Amadihttps://www.wilmerhale.com/brittany_amadi/brittany.amadi@wilmerhale.com

On May 3, Wilmer Cutler Pickering Hale and Dorr co-hosted a seminar in the London office with the Brazilian Arbitration Committee (Comitê Brasileiro de Arbitragem – CBAr) titled “What to Expect When Arbitrating in Brazil: Recent Developments of International Arbitrations and Institutional Landscape.”

2018-05-15T00:00:00-04:002018-05-16T13:43:43Z

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, has announced the closing of its previously announced registered underwritten public offering and the exercise in full of the underwriters' option to purchase additional shares. 

2018-05-08T00:00:00-04:002018-05-09T16:10:20Z

Partner Jamie Gorelick, along with other former and current top federal policymakers, participated in a tabletop exercise meant to better understand the kinds of high-level decisions that would be necessary in the event of an actual pandemic global outbreak of a potentially deadly pathogen.

2018-05-15T00:00:00-04:002018-05-16T18:23:04Z

In a case argued by Partner Seth Waxman on behalf of a Louisiana death-row inmate, the US Supreme Court on Monday, May 14, 2018, overturned several murder convictions and ordered a new trial after finding that the condemned man's trial attorney violated his constitutional rights. 

2018-05-15T00:00:00-04:002018-05-15T14:23:15Z

Nantero Inc., a nanotechnology company developing next generation memory using carbon nanotubes, announced that it has expanded product development with a wide range of new and existing customers. 

2018-05-08T00:00:00-04:002018-05-08T19:49:34Z

Casella Waste Systems, Inc., a regional solid waste, recycling and resource management services company, announced that it has entered into a $550 million credit facility with Bank of America, N.A., as administrative agent and swing line lender, Merrill Lynch, Pierce Fener & Smith Incorporated, Citizens Bank, N.A., JPMorgan Chase Bank N.A. and Comerica Bank as joint lead arrangers and joint bookrunners, and certain other agents and lenders.

2018-05-15T00:00:00-04:002018-05-15T14:39:52Z

Soft Robotics Inc., a Cambridge, Massachusetts-based company that designs and manufactures robotic grippers capable of manipulating a wide variety of items without the help of computer vision, has announced the closing of a $20M fundraising round. 

2018-05-08T00:00:00-04:002018-05-08T18:44:05Z

WilmerHale and the American Civil Liberties Union of Massachusetts successfully convinced the US government to release Lucimar de Souza, a non-citizen who had been detained by Immigration and Custom Enforcement for more than three months, separating her from her US citizen husband and 10-year-old son.

2018-05-15T00:00:00-04:002018-05-15T17:48:31Z

On May 1, 2018, Sebela Pharmaceuticals completed the acquisition of Braintree Laboratories Inc., a privately held specialty pharmaceutical company based in Braintree, Massachusetts. Braintree develops, manufactures and markets specialty pharmaceuticals in gastroenterology.

2018-05-10T00:00:00-04:002018-05-10T19:55:29Z

On May 8, President Trump announced that the United States would end its participation in the Joint Comprehensive Plan of Action.

2018-05-10T00:00:00-04:002018-05-10T15:31:37ZRonald I. Meltzerhttps://www.wilmerhale.com/ronald_meltzer/ronald.meltzer@wilmerhale.comDavid S. Cohenhttps://www.wilmerhale.com/david_cohen/david.cohen@wilmerhale.comDavid M. Hornhttps://www.wilmerhale.com/david_horn/david.horn@wilmerhale.comZachary Goldmanhttps://www.wilmerhale.com/zachary_goldman/zachary.goldman@wilmerhale.comSemira Nikouhttps://www.wilmerhale.com/semira_nikou/semira.nikou@wilmerhale.comRussell Spivakhttps://www.wilmerhale.com/russell_spivak/russell.spivak@wilmerhale.com

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, has announced the closing of its previously announced registered underwritten public offering and the exercise in full of the underwriters' option to purchase additional shares. 

2018-05-08T00:00:00-04:002018-05-09T16:10:20Z

Nantero Inc., a nanotechnology company developing next generation memory using carbon nanotubes, announced that it has expanded product development with a wide range of new and existing customers. 

2018-05-08T00:00:00-04:002018-05-08T19:49:34Z